Skip to content

Jaakko Lappalainen, MD, PHD

NPI 1518383587ActiveIndividual· Psychiatry & Neurology, Addiction Psychiatry· Philadelphia, PA

Psychiatry & Neurology, Addiction Psychiatry (MD, PHD) in Philadelphia, Pennsylvania, licensed in PA and CT, with an NPI issued in March 2014. Part D covered 159 prescriptions written in 2024, 87% of them generic. Abbvie Inc. was the largest of 5 companies reporting payments in 2025, $276.26 in all, mostly food and beverage.

Overview

NPI1518383587
StatusActive
Entity typeIndividual
CredentialMD, PHD
Sole proprietorYes
NPI issuedMar 13, 2014
Last updated in NPPESMar 13, 2014

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Psychiatry (PA)

Part D prescriptions in 2024

Prescriptions (claims)159 · 159 30-day fills
Patients24
Total drug cost$36,092
Generic share87% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$276.26 · 16 payments from 5 companies
  • 2024$187.59 · 5 payments from 3 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$276.26 · 16 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Psychiatry & Neurology, Addiction Psychiatry providers in Philadelphia

All Psychiatry & Neurology, Addiction Psychiatry providers in Pennsylvania